Home  |   Archive  |   Online Submission  |   News & Events  |   Subscribe  |   APFA  |   Society  |   Contact Us  |   中文版

Ahead of print
Authors' Accepted
Current Issue
Special Issues
Browse by Category

Manuscript Submission

Online Submission
Online Review
Instruction for Authors
Instruction for Reviewers
English Corner new!

About AJA

About AJA
Editorial Board
Contact Us

Resources & Services

Email alert

Download area

Copyright licence
EndNote style file
Manuscript word template
Guidance for AJA figures
    preparation (in English)

Guidance for AJA figures
    preparation (in Chinese)

Proof-reading for the

AJA Club (in English)
AJA Club (in Chinese)


Volume 19, Issue 5 (September 2017) 19, 512–514; 10.4103/aja.aja_14_17

Testosterone treatment in older men: glass half empty or half full?

Brendan J Nolan1, Mathis Grossmann1, 2

1 Department of Endocrinology, Austin Health, Heidelberg, Victoria 3084, Australia
2 Department of Medicine, University of Melbourne, Austin Health, Heidelberg, Victoria 3084, Australia

Correspondence: Prof. M Grossmann (mathisg@unimelb.edu.au)

Date of Submission 13-Mar-2017 Date of Acceptance 06-Apr-2017 Date of Web Publication 26-May-2017


In a series of randomized controlled trials published in JAMA and JAMA Intern Med, US researchers have examined the effect of testosterone treatment in older men with testosterone levels <275 ng dl−1 on coronary artery plaque volume,[1] cognitive function,[2] anemia,[3] and volumetric bone density.[4] While the trials have shown positive results with respect to improvement in anemia and bone density, longer-term studies are required to delineate the long-term risks and benefits in this population.

Full Text | PDF |

Browse:  2273
Asian Journal of Andrology CN 31-1795/R ISSN 1008-682X  Copyright © 2023  Shanghai Materia Medica, Chinese Academy of Sciences.  All rights reserved.